Forecasts and insights to guide your planning

Welcome to the Winter 2021 issue of the newly renamed Vizient® Pharmacy Market Outlook (formerly the Drug Price Forecast), delivering drug price projections and insights.

In this issue:

  • Strategic role of pharmacy since the COVID-19 on medication use and financial outcomes based on care settings
  • Drug price projections over the next 6-18 months
  • A review of regulatory events and policy changes
  • Insights from Vizient members on the management of COVID-19 vaccines

Get the latest Pharmacy Market Outlook

2.67 %

Projected drug price inflation rate through June 30, 2022

Graph Chart

Preview of insights

  • Adalimumab continues to drive increases in both price and usage. Spend for adalimumab in the U.S. exceeded $24 billion for 2020, and no biosimilar competition is likely until 2023.
  • The specialty drug inflation rate is much higher than the predicted overall rate of 2.67%, so budgeting for specialty products will be especially important in the next 18 months.
  • Oncology drugs continue to dominate drug spend, accounting for 24.67% of member spend.

Learn more

Learn how our pharmacy experts can help guide your recovery and planning